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a  b  s  t  r  a  c  t
Recombinant  Chinese  Hamster  Ovary  (CHO)  cells  producing  IgG  monoclonal  antibody  were  cultivated  in a
novel  perfusion  culture  system  CellTank,  integrating  the  bioreactor  and  the  cell  retention  function.  In this
system,  the cells  were  harbored  in a non-woven  polyester  matrix  perfused  by  the  culture  medium  and
immersed  in a reservoir.  Although  adapted  to suspension,  the  CHO  cells  stayed  entrapped  in the  matrix.
The  cell-free  medium  was  efﬁciently  circulated  from  the  reservoir  into-  and  through  the  matrix  by a
centrifugal  pump  placed  at the  bottom  of  the  bioreactor  resulting  in  highly  homogenous  concentrations
of  the nutrients  and  metabolites  in the  whole  system  as  conﬁrmed  by  measurements  from  different
sampling  locations.  A real-time  biomass  sensor  using  the  dielectric  properties  of  living cells  was  used  to
measure  the  cell  density.  The  performances  of  the  CellTank  were  studied  in three perfusion  runs.  A  very
high cell  density  measured  as  200  pF/cm  (where  1  pF/cm  is  equivalent  to 1 ×  106 viable  cells/mL)  was
achieved  at a perfusion  rate  of  10 reactor  volumes  per  day  (RV/day)  in the  ﬁrst  run.  In the  second  run,
the  effect  of  cell  growth  arrest  by  hypothermia  at temperatures  lowered  gradually  from  37 ◦C to 29 ◦C
was  studied  during  13  days  at cell  densities  above  100  pF/cm.  Finally  a production  run  was  performed
at  high  cell  densities,  where  a temperature  shift  to 31 ◦C  was  applied  at cell  density  100  pF/cm  during  a
production  period  of  14  days  in minimized  feeding  conditions.  The  IgG  concentrations  were  comparable
in  the  matrix  and  in  the  harvest  line  in all the  runs,  indicating  no  retention  of the product  of  interest.  The
cell  speciﬁc  productivity  was comparable  or higher  than  in  Erlenmeyer  ﬂask  batch  culture.  During  the
production  run,  the  ﬁnal  harvested  IgG  production  was  35  times  higher  in the  CellTank  compared  to  a
repeated  batch  culture  in the  same  vessel  volume  during  the  same  time  period.
©  2015  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
Perfusion bioprocesses have several advantages compared with
atch/fed-batch processes such as a potential high cell density, a
igh productivity in a relatively small size bioreactor, a stable cell
nvironment and long-term production (Castilho and Medronho,
002; Chotteau, 2015; Chu and Robinson, 2001; Langer, 2011;
oisard et al., 2003).
Abbreviations: CHO, Chinese Hamster Ovary; CSPR, cell speciﬁc perfusion rate;
O,  dissolved oxygen; HPLC, high-performance liquid chromatography; LDH, lactate
ehydrogenase; RV/day, reactor volume per day.
∗ Corresponding author.
E-mail addresses: yezhang@kth.se (Y. Zhang), chotteau@kth.se (V. Chotteau).
1 Presently Serendipity Innovations, Stureplan 15, SE-11145 Stockholm, Sweden.
ttp://dx.doi.org/10.1016/j.jbiotec.2015.07.006
168-1656/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
Perfusion processes have become increasingly accepted in the
past decade for the commercial manufacturing of biopharma-
ceuticals due to, on one hand, the increasing use of disposable
bioreactor systems alleviating the technical and sterility chal-
lenges, the need of ﬂexibility and smaller equipment footprint for
manufacturing, and, on the other hand, the emergence of robust
perfusion systems, e.g., the alternating tangential ﬂow ﬁltration
(Clincke et al., 2013a,b). Another ﬁeld of application of perfu-
sion processes is the production of biologics as research tools
where given amounts of protein products are needed within a very
short time period. For this kind of application, quite often nei-
ther the cell line nor the process/cultivation medium is optimized.
High cell densities potentially provided by the perfusion mode
can advantageously compensate for these sub-optimal conditions.
Furthermore, perfusion mode offers a stable and continuously
renewed cell environment favorable for the control of the product
quality and can be necessary in the case of labile proteins.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
iotech
t
(
O
c
m
a
c
c
m
1
p
d
t
t
I
m
r
t
s
h
r
d
c
e
c
q
i
c
c
2
c
t
p
t
i
(
b
c
s
o
m
w
f
c
1
T
t
t
c
u
o
t
b
i
d
t
l
p
(
2
a
eY. Zhang et al. / Journal of B
In perfusion mode the cells are retained inside the bioreac-
or by anchoring them to a support, i.e., membrane, matrix, etc.,
Meuwly et al., 2007) or by a cell retention device (Kompala and
zturk, 2005). The former often applies to anchorage-dependent
ells and the latter to suspension cell lines for which various com-
ercial cell retention systems are available, based on e.g., ﬁltration,
cceleration. Several commercial systems based on anchoring the
ells are available such as packed-bed with immobilized micro-
arriers (Bohak et al., 1987; Looby and Grifﬁths, 1988), ceramics
atrix (Mitsuda et al., 1991), hollow ﬁber bioreactors (Knazek et al.,
972). Other techniques where the cells are entrapped in large
olymer matrix have also been proposed: Lee et al. (2005) have
eveloped a system in which the cells are entrapped in a depth ﬁl-
er, through which the medium is circulated by a peristaltic pump
o a second tank equipped with monitoring and control systems.
n a typical ﬁbrous bioreactor, the cells are anchored in a ﬁbrous
atrix immersed in a tank and homogenized by magnetic stir-
ing (Chen et al., 2002). In such bioreactor systems, gradients of
he nutrients, gas composition, accumulation of dead cells in the
upporting matrices and by-products heterogeneous distribution
ave often been reported, see for instance de la Broise’s or Piret’s
eports (de la Broise et al., 1992; Piret and Cooney, 1990). These gra-
ients are sub-optimal since they may  cause a non-homogeneous
ell environment with variations of the concentrations of the nutri-
nts and toxic by-products, as well as an uneven distribution of the
ell population. These can cause differential production in terms of
uantity and quality of the product, cell selection and even necrosis
n extreme cases.
Oh and Chang (1992) achieved a density of 187 × 106 hybridoma
ells/mL in a dual hollow ﬁber bioreactor and up to 38.1 × 106 Vero
ells/mL (Choi et al., 1995) and 33.5 × 106 CHO cells/mL (Lee et al.,
005) were reported using depth ﬁlter perfusion systems. These
ell densities were estimated from either the cell speciﬁc produc-
ivity (Lee et al., 2005; Oh and Chang, 1992) or speciﬁc metabolite
roduction/consumption rates (Choi et al., 1995), postulating that
hese speciﬁc rates were constant, which could not be veriﬁed, lead-
ng to uncertainty: for instance, for the same experiment Oh et al.
1994) reported maximal densities of 3 × 107 and 6 × 107 cells/mL
ased on either the cell speciﬁc glucose consumption rate or the
ell speciﬁc IgG production rate (qIgG) using a depth ﬁlter perfusion
ystem.
In bioreactors with immobilized cells, cell sampling is difﬁcult
r impossible to perform but bioimpedance sensing can be used to
onitor the biomass. Bioimpedance or dielectric spectroscopy is
idely used as online biomass monitoring of upstream processes
or different cell types such as yeast, bacteria, insect, mammalian
ells (Ansorge et al., 2007; Carvell and Dowd, 2006; Harris et al.,
987; Kaufmann et al., 1999; Sarra et al., 1996; Zeiser et al., 1999).
he bioimpedance biomass sensor utilizes the dielectric proper-
ies of living cells with intact plasma membrane. Due to the fact
hat the cell plasma membranes are poor electrical conductor, the
ells act as small capacitors in an electrical ﬁeld with charge built
p on the membranes (Kaufmann et al., 1999). Applying a peri-
dically alternating electrical ﬁeld to the cell culture, the lag in
he system response, caused by the polarization of the cell mem-
ranes, is detected as capacitance/permittivity signal. This signal
s a function of the frequency of the electrical ﬁeld switch and
epends of the characteristic of the cells but the contribution from
he medium components, the dead cells, the cell debris, etc. is neg-
igible. Bioimpedance has been proposed as a promising tool for
rocess analytical technology (PAT) introduced by the FDA in 2004
Clementschitsch and Bayer, 2006; Gnoth et al., 2007; Teixeira et al.,
009).
Lowering the culture temperature in perfusion cultivations to
rrest the cell growth and enhance qIgG has been reported by oth-
rs (Ahn et al., 2008; Chen et al., 2004; Ducommun et al., 2002b;nology 213 (2015) 28–41 29
Rodriguez et al., 2010; Tsai et al., 1996) and offers a simple approach
to maintain the cell density.
The bioreactor used in the present study, CellTank, is a new con-
cept that has been developed to perfuse adherent or non-adherent
mammalian cells at high density. It is a compact disposable system
where the cells are entrapped in a non-woven polyester matrix
caged in a cassette and immersed in a reservoir. The cultiva-
tion medium rapidly circulates continuously through the matrix
pumped by a centrifugal pump integrated in the reservoir. The
CellTank has some common features with e.g., the packed bed, the
ﬁbrous bioreactor or the hollow ﬁber bioreactor hence the cells are
immobilized while the medium is circulated. However the biore-
actor design and technology are quite different. The system can
operate with suspension cells and has been designed to ensure a
highly homogeneous distribution of the ﬂuid in the matrix.
In the present study, CellTank bioreactors were used to culti-
vate a suspension CHO K1 cell line producing recombinant IgG.
Three perfusion runs were performed aiming at evaluating the
performance of the CellTank. The purpose of the ﬁrst run was to
investigate the capacity of the CellTank to support high cell densi-
ties. In the second run, the effect of hypothermia on the growth and
production at high cell density was  studied. A selected temperature
switch was  ﬁnally applied in the third culture at 100 pF/cm cell
density, and the stability as well as reproducibility of the CellTank
performances were examined.
2. Materials and methods
2.1. Cell line and media
CHO DP-12 clone #1934 (ATCC) cells producing an IgG mon-
oclonal antibody were adapted to suspension and serum-free
culture in animal component-free IS CHO CD XP medium with
hydrolysate (Irvine Scientiﬁc, USA), supplemented with 4 mM
l-glutamine. The cells were expanded in 250 mL  or 500 mL  Erlen-
meyer ﬂasks (100 rpm agitation, 37 ◦C, 5% CO2). The medium
for perfusion cultivation was  IS CHO CD XP medium with
hydrolysate, supplemented with 3% IS CHO FEED CD XP (Irvine
Scientiﬁc, USA) and 0.1 mg/mL  streptomycin/100 mL/U penicillin
G/0.25 g/mL amphotericin B (all Sigma–Aldrich, USA). Additional
supplementations of 15–30 mM d-(+)-glucose (stock solution 45%,
Sigma–Aldrich, USA) and 1–4 mM l-glutamine (stock solution
200 mM,  Irvine Scientiﬁc, USA) were performed to compensate for
the cell consumption.
2.2. Set-up and equipment
The cultivation runs were performed in e-beam irradiated Cell-
Tank prototypes manufactured at PerfuseCell (2 L total volume),
containing a 150 cm3 non-woven matrix cassette immersed in
1 L culture medium. The matrix was composed of spun polyester
ﬁbers with diameter 20 m and pore size less than 0.5 mm.  The
pH, dissolved oxygen (DO) and temperature were monitored and
controlled with a Biophantom process control system (Belach
Bioteknik, Sweden). The cell biomass was monitored by an iBiomass
EVO 200 system at frequencies 1000 kHz and 10 MHz  (Fogale Nan-
otech, France), with sampling every 120 s. The cell concentration
was based on the cassette volume of 150 mL  and a reading of
1 pF/cm corresponded to 1 × 106 viable cells/mL, see Section 3.2
for details. A dummy  biomass probe was pre-installed in the mid-
dle of the matrix during e-beam irradiation and was replaced by an
autoclaved biomass probe installed inside a laminar ﬂow cabinet.
The probes of pH and DO (Broadley–James) were autoclaved and
mounted in the reservoir. The pH (set-point 7.0) was controlled
by automatic addition of Na2CO3 0.5 M or CO2 into the reservoir
30 Y. Zhang et al. / Journal of Biotechnology 213 (2015) 28–41
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eadspace. The temperature sensor was mounted in a pouch plung-
ng in the reservoir. The temperature was controlled using a heating
lanket (100 W,  24 V) around the reservoir. The medium recircula-
ion in the bioreactor was performed by an integrated centrifugal
ump that was magnetically driven by a stirrer located under the
ioreactor (two stirrer prototype systems were used manufactured
y Belach and by PerfuseCell, respectively). The recirculation ﬂow
ate could be read on the rotameter (0.4–2.4 L/min) at the exit of
he cassette and adjusted by varying the magnetic stirring speed of
he centrifugal pump. A detailed sketch for the centrifugal pump is
rovided as Supplementary material. The medium perfusion was
erformed in the reservoir by two peristaltic pumps (Watson-
arlow 120U). The feed medium was prepared every day with
lutamine and glucose additions calculated to compensate for the
ell consumption. Fig. 1 illustrates the general set-up.
Supplementary material related to this article found, in the
nline version, at http://dx.doi.org/10.1016/j.jbiotec.2015.07.006
A continuous gas mix  of air, N2 and CO2 was added into the
eadspace to steadily maintain a slight overpressure, ensuring the
terility of the system, and maintaining pCO2 > 2 kPa. Due to the
mall culture volume (150 cm3 matrix cassette), the DO was  above
he set point (40%) with only air addition at low or medium cell den-
ities. Therefore air (0–100 mL/min) and N2 (0–150 mL/min) were
anually mixed at a concentration lower than 40% air. The DO was
utomatically controlled upwards by adding O (0–60 mL/min) to2
he headspace or through a sparger in the reservoir. The sparger
onsisted of an obturated dip tube punctured with holes. The gas
utlet was expelled via a ‘bubble ﬂask’, i.e., a sterile ﬂask half ﬁlledhe bioreactor. The arrows indicate the direction of ﬂuid recirculation inside the
he matrix (50× magniﬁcation).
with water in which the outlet gas was bubbling. Pressure inside the
cassette was  measured by a tube vertically mounted on top of the
matrix, see Fig. 1. The liquid level in this tube was a linear indicator
of the pressure inside the matrix, i.e., similarly to a barometer.
2.3. Methods
The CellTank was inoculated from Erlenmeyer ﬂask cultures in
exponential growth phase at 1 × 106 viable cells/mL for run#1 and
run#2 using the feed-in line into the reservoir and the recirculation
ﬂow rate was set to 1.0 L/min. Run#3 was seeded at 2 × 106 viable
cells/mL. The perfusion was  initiated when the cell reached 2 pF/cm
in the matrix after growing them in batch mode. The recirculation
ﬂow rate was then maintained at 1.6 L/min until the end of the runs.
Samples from the reservoir, the matrix (from a hole drilled in the
matrix) and the harvest line were daily taken.
A cell speciﬁc perfusion rate (CSPR) of 0.05 nL/cell/day (or
1/20 nL/cell/day) based on the reactor volume of 150 mL, which is
the volume of the cassette, was adopted (Clincke et al., 2013b). To
implement this CSPR, a practical way to calculate the perfusion rate
(unit = RV/day) as a function of the viable cell density (Cv) given in
Eq. (1), was used.
Perfusion rate = CSPR Cv = 0.05 Cv = Cv (1)20
Furthermore the perfusion rate was  manually increased above the
value given by Eq. (1) when the levels of ammonia or lactate
exceeded 4.8 mM  and 50 mM,  respectively.
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.4. Analytical methods
.4.1. Quantiﬁcation methods
The density of the cells leaking from the matrix, i.e., present in
he reservoir, the pH, pCO2, pO2, osmolality, concentrations of glu-
ose, lactate, glutamine, glutamate and ammonia, were measured
y Bioproﬁle FLEX (Nova Biomedical). The perfusion rate was  calcu-
ated based on the matrix volume (150 cm3) by weighting the feed
edium and harvest bottles. The cell viability was determined by
easuring the activity of lactate dehydrogenase (LDH) (cytotoxi-
ity enzymatic assay, Promega) to determine the concentration of
ead cells, Cdead, in the daily harvest samples. A standard curve
f released LDH activity was made from lysing known numbers of
ells. The viability was then calculated as
Cvvolmatrix100%
Cvvolmatrix + Cdead (volreservoir + volmatrix (D − 1))
(2)
here Cv is the viable cell density measured by the biomass
ensor, volmatrix is the matrix volume, volreservoir is the reser-
oir volume, D is the perfusion rate. The IgG quantiﬁcation was
one by high-performance liquid chromatography (HPLC) Pro-
ein A method (Protein A column, Applied Biosystems, USA).
aily samples were puriﬁed and concentrated with NAb Pro-
ein A/G spin kit (Thermo Scientiﬁc, USA) and reducing sodium
odecyl sulfate-polyacylamide gel electrophoresis (SDS-PAGE) was
erformed. The cell speciﬁc consumption/production rates of nutri-
nts/metabolites, the accumulated IgG production, the cell speciﬁc
roductivity and the volumetric productivity were calculated as
reviously described (Clincke et al., 2013a,b).
.4.2. Microscopic observation of the cells and total cell
numeration
At the end of run, the CellTank was disassembled and the matrix
isks were analyzed. Slices were orthogonally cut from each disk
sing a scalpel and microscopic analyses were carried out to study
he cell distribution. The rest of the disks were cut into large pieces
nd placed in several shake ﬂasks containing fresh medium, one
isk in one ﬂask. After vigorous shaking at 200 rpm for 30 min
ttempting to release all the cells from the matrix, the cell broths
ere analyzed by Bioproﬁle FLEX for a total cell number counting.
he slices were observed under bright ﬁeld microscope (inverted
icroscope Leica DMI6000b) at the cuts showing cells and cut
bers. The cells in the matrix were also ﬁxed with 4% paraformalde-
yde followed by DAPI ﬂuorescent staining of the nuclei. The cell
istribution was then observed by ﬂuorescence microscopy up to
 depth of 300 m (inverted microscope Leica DMI6000b).
. Results and discussion
.1. Bioreactor design
A schematic representation of the CellTank is given in Fig. 1. The
ells are entrapped in a non-woven spun-ﬁber polyester matrix in
 cassette, which is immersed in a reservoir. The matrix is designed
s a cylinder with two slightly angled envelopes containing 18 mm-
hick stacked disks (totally 10 disks). The disks have 50 cm2 inlet
urface area and about 80 mL  volume resulting in a total volume
f 150 mL  for the whole matrix. The culture medium is continu-
usly circulating in the whole system: in the reservoir the liquid is
ushed upwards into the matrix by a magnetically driven centrifu-
al pump under the cassette. The liquid enters into the cassette
ore center and ﬂows orthogonally through each matrix disk as
ndicated in Fig. 1. After having passed the matrix, the liquid is
ollected at the median part of the matrix and then pushed into
 rotameter, measuring the liquid recirculation mass ﬂow. At the
op of the rotameter, the liquid is pouring back into the reservoir,nology 213 (2015) 28–41 31
which gives a very effective exchange with the gas phase. During
the perfusion mode, the recirculation of the liquid in the Cell-
Tank is very fast, 1.6 L/min, i.e., 10.7 VVM (volume per volume per
minute) for a matrix volume of 150 mL.  However the cells mostly
remained trapped inside the porous matrix, captured in the tortu-
ous ﬂow path created by the series of interconnected void spaces
of the micro ﬁlter structure. This fast recirculation ﬂow ensures a
homogeneous distribution of the ﬂuid in the matrix. The centrifugal
pump is manually operated at 250–600 rpm, resulting in a poten-
tial ﬂow rate of 0–3 L/min. The required centrifugal pump effect to
ensure the selected ﬂow rate depends on the cell density: the higher
the cell density, the higher the centrifugal pump rotation and power
input. A power of 25 watts is required to overcome a 25 mbar pres-
sure difference across the cell packed matrix in absence of cells.
Sparging is operated in the reservoir. The sparged bubbles are never
entering the matrix and are thus never in contact with the cells.
The perfusion is carried out by adding fresh medium in the reser-
voir and removing conditioned medium from the rotameter, by two
peristaltic pumps set at the same ﬂow rate. In the present study, the
pumps were run intermittently due to the small perfusion volumes,
150–1500 mL/day.
3.2. Cell density measurement by the biomass sensor
To our knowledge, the highest cell density measured by a Fogale
bioimpedance biomass probe, that has been reported by off-line
measurements is 20 × 106 cells/mL (Heinrich et al., 2011). How-
ever, in the present experiments, we  reached densities well beyond
this number. To conﬁrm the reliability of the biomass measured
by the biomass probe, we compared the cell density measured
by this probe with suspensions of CHO DP-12 cells of different
known cell densities. Cells exponentially grown in Erlenmeyer
ﬂasks were concentrated by centrifugation. The biomass sensor,
‘on-line measurement’, was placed in this concentrated cell culture
and serial dilutions of the cell broth by medium were performed.
The biomass readings were compared to the cell density measured
using a Bioproﬁle FLEX instrument, ‘off-line measurements’ based
on Trypan blue exclusion and image analysis. Each off-line mea-
surement was an average of three values obtained by three different
dilutions in fresh medium before measuring by Bioproﬁle FLEX.
Fig. 2 was  generated from duplicated experiments performed at
different days. It shows that the reading from the biomass sensor
agreed very well with the cell density measured by the Bioproﬁle
FLEX up to 160 × 106 viable cells/mL, with 1 pF/cm correspond-
ing to 1 × 106 viable cells/mL. Above this value the biomass sensor
underestimated the cell densities and the biomass sensor read-
ing saturated at a value around 203 pF/cm. Although this system
was slightly different from the perfusion runs since fresh medium
was used instead of conditioned medium, this comparison con-
ﬁrmed that 1 pF/cm was  equivalent to 106 viable cells/mL up to
160 × 106 viable cells/mL density.
3.3. Investigation of CellTank performance limit and cell growth
arrest
The purpose of run#1 was to test the CellTank and to study the
cell density limit of the system. Run#2 aimed at studying the system
behavior during cell growth arrest.
3.3.1. Cell density
Run#1 and run#2 were initiated by inoculating the reservoir
with 150 × 106 viable cells, aiming at an initial cell density of 106
viable cells/mL in the 150 mL  matrix. The recirculation ﬂow was
set to 1.0 L/min before the perfusion initiation, after which it was
increased to 1.6 L/min and maintained at this value. Sampling from
the reservoir 20 min  after the inoculation showed that 75% of the
32 Y. Zhang et al. / Journal of Biotechnology 213 (2015) 28–41
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ays.
ells were entrapped in the matrix and above 95% within 2 h fol-
owing the inoculation.
Run#1 was a pioneer trial to study the system performance for
 culture of cells in suspension and the capacity of the CellTank to
upport high cell densities. During the ﬁrst two weeks of this run,
he cell growth was slow due to troubleshooting and system adjust-
ents, then from day 14, the cells grew exponentially. The cell
ensity reached a maximal biomass reading of 200 pF/cm on day 26,
ee Fig. 3A. As presented above, the EVO reading was  not linear with
he cell density above 160 × 106 cells/mL but was underestimating
he cell density. One can therefore afﬁrm that the cell density was
200 × 106 viable cells/mL for the reading of 200 pF/cm. The den-
ity of the cells outside the matrix, i.e., in the reservoir was very
ow: ≤0.05 × 106 viable cells/mL before day 21 and up to 0.8 × 106
iable cells/mL after day 21, while the live cell density in the matrix
as ≥82 pF/cm. The number of dead cells measured by LDH assay
as low and increasing with time with a pattern roughly compa-
able to the viable cell density, resulting in a viability mostly ≥90 %
uring the whole run.
In run#2, the cells grew exponentially from day 1 (Fig. 3B). To
tudy the potential of a process with cell density stabilized by cell
rowth arrest at high cell density in CellTank, a temperature shift
tudy was carried out. The temperature was lowered from 37 ◦C
o 32 ◦C when the biomass reading reached 97 pF/cm on day 10.
his temperature notably reduced the growth. Further temperature
eductions were then performed on day 11 to 31 ◦C, on day 14 to
0 ◦C and on day 16 to 29 ◦C, which eventually provoked a complete
rowth arrest. The hypothermia resulted in a viable cell density
tabilized around 130 pF/cm maintained for 9 days, from day 14 to
ay 22. The cell viability was ≥90% during the whole run. The num-
er of cells leaking from the matrix, represented in Fig. 3B, was
ery low compared to the number of cells entrapped in the matrix:
t increased slightly from 0.1 × 106 cells/mL to 0.3 × 106 cells/mL-line biomass sensor measurements by Fogale biomass probe in a concentrated cell
is added for clarity. The curves include data from duplicates performed on different
after the temperature reduction on day 10 and increased up to
1.2 × 106 cells/mL after day 20.
3.3.2. Perfusion rate and recirculation rate
The perfusion was initiated at a rate of 1 RV/day and then
increased linearly with the cell density. Further increases of the
perfusion rate were also performed to reduce the by-product lev-
els as described in Section 2. In run#1, at 200 pF/cm the perfusion
rate was  10 RV/day on day 25. In this run, the perfusion rate was
increased at a value higher than the CSPR (Eq. (1)) on day 5 and day
21 when the ammonia level reached 4.8 mM and 6 mM,  respectively
(Fig. 4B).
In run#2, the perfusion rate was  adjusted according to Eq.
(1) except two  times, when the ammonia level reached 5 mM
on day 5 and when the lactate and ammonia levels reached 50
and 8 mM respectively on day 8, see Fig. 4C and D. Noticeably
despite a reduced metabolism, consecutive to the growth arrest,
the lactate concentration increased hence the perfusion rate was
increased accordingly up to 10 RV/day. Reducing the perfusion rate
to 8 RV/day on day 21 resulted in a new increase of the lactate level.
The recirculation rate was measured by reading of the rotameter
and manually controlled by adjusting the centrifugal pump stirring
speed. Table 1 shows the relationship between the cell density in
the matrix, the recirculation ﬂow, the pressure inside the matrix,
and the centrifugal pump stirring speed. The stirring speed was
constant and the pressure at the outlet of the centrifugal pump was
stable, around 0.030 bar, during the exponential cell growth until
100 × 106 cells/mL, i.e., until day 10. After that day, the pressure
obtained from the centrifugal pump to maintain the recirculation
rate at its 1.6 L/min set point, was  incrementally increased every
day: an increase of approximately 15 rpm per day of the stirrer
speed was needed to ensure this required pressure. A very high
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Fig. 3. Cell growth proﬁles for run#1 and run#2. (A) Run#1; (B) run#2.
Table 1
Cell density, recirculation ﬂow, pressure, and stirring speed for run#2 with temperature lowered gradually.
Time (days) Cell density (pF/cm) Mass ﬂow (L/min) Pressure (mm)  Stirring speed (rpm) Theoretical pressure (bar)
1 2.61 1.6 300 300 0.029
2  3.82 1.6 305 300 0.030
3  6.52 1.6 310 300 0.030
4  11.35 1.5 295 300 0.029
5  18.08 1.6 315 300 0.031
6  26.75 1.6 310 300 0.030
7  37.38 1.5 305 300 0.030
8  53.23 1.6 305 300 0.030
9  74.81 1.5 330 300 0.032
10  97.68 1.6 330 300 0.032
11  106.03 1.6 350 325 0.034
12  101.1 1.5 370 340 0.036
13  110.78 1.6 380 355 0.037
14  125.94 1.5 385 370 0.038
15  132.77 1.5 350 385 0.034
16  143.77 1.55 420 400 0.041
17  140.88 1.6 440 425 0.043
18  139.98 1.6 450 440 0.044
19  138.08 1.5 460 440 0.045
20  136.65 1.5 450 450 0.044
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d21  132.33 1.6 
22  131.24 1.6 
23  129.36 1.6 
orque was ﬁnally required from the magnetic stirrer towards the
nd of the run to push the recirculation medium through the matrix.
It is probable that the required pressure increased due to the
hysical hindrance created by the cells and the cell debris inside
he matrix..3.3. Information of the biomass sensor
The principle of dielectric spectroscopy and the -dispersion
odel of the permittivity measurement have been abundantly
escribed elsewhere (Ansorge et al., 2007; Carvell and Dowd, 2006; 460 0.046
 460 0.046
 460 0.048
Ducommun et al., 2002a; Harris et al., 1987; Kaufmann et al., 1999;
Noll and Biselli, 1998; Sarra et al., 1996; Zeiser et al., 1999) and
used to determine the cell density in suspension or in adherence on
microcarriers in bioreactor. One of the key parameters, the charac-
teristic (or critical) frequency fc, is calculated from the permittivity
scanning data and is always regarded as a reciprocal indicator of
cell size. Cole–cole alpha is an empirical parameter considered as
an indicator of the size homogeneity (Markx et al., 1991). The read-
ings measured by the biomass sensor for run#1 are given in Fig. 5.
From day 16, fc declined, suggesting that the cells became larger.
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oncentrations in run#1; (B) glutamine and ammonia concentrations in run#1; (C) 
n  run#2.
uring the cultivation, cole–cole alpha was increasing, indicating an
ncreasing inhomogeneity of the cell sizes. At the high cell density of
00 pF/cm, an upper limit of 1000 pF/cm of the permittivity varia-
ion DeltaEps was reached, leading to the saturation of the biomass
eading. From day 19, the conductivity began to decrease, dropping
o almost half its starting value at the end. This might be associ-
ted to a modiﬁcation of the ion cellular uptake from the medium.
inally, a very high correlation between the biomass (calculated
rom 2 frequencies) and DeltaEps (all frequencies) was observed.
.3.4. IgG production
The IgG concentrations in the bioreactor as well as the cell
peciﬁc productivities (qIgG) are represented in Fig. 6. The IgG con-
entrations in the matrix and in the harvest line were comparable
ence a yield close to 100% was obtained indicating no retention of
he IgG in the bioreactor. The qIgG was in average 1.7 pg/cell/day in
un#1 as well as in run#2 until day 14. This value was comparable
r slightly higher than the qIgG of 1.5 pg/cell/day measured in Erlen-
eyer ﬂask batch cultures. When the temperature was decreased
o 30 ◦C in run#2, qIgG increased to an average of 2.5 pg/cell/day, i.e.,
7% higher than at 37 ◦C. When the temperature was  further low-
red to 29 ◦C from at day 16, qIgG decreased to ≈2 pg/cell/day. Thus
he optimal temperature maximizing the cell speciﬁc productivity
as 30 ◦C for this cell line. locations: matrix, harvest line and bottom of the reservoir. (A) Glucose and lactate
e and lactate concentrations in run#2; (D) glutamine and ammonia concentrations
To study if fragmented variants occurred when the cell density
was increased, reducing SDS-PAGE was  performed for both runs,
see Fig. 7A and B. These analyses were repeated showing exactly
the same results (data not shown). As can be seen in Fig. 7, both the
heavy chain and light chain bands showed high similarities from
27 pF/cm to 200 pF/cm biomass readings at 37 ◦C temperature. A
faint band (“2nd band” in Fig. 10B) with a slightly lower molecu-
lar weight than the main light chain band (“1st band”), increased
in intensity with decreasing temperatures. The 2nd band became
stronger at 30 ◦C temperature and even darker than the 1st light
chain band at 29 ◦C. These results indicate that no fragment vari-
ant occurred at 37 ◦C culture temperature up to 200 pF/cm biomass
reading. A variant of the light chain was  observed when hypother-
mia  was applied, with an intensity increasing with decreasing
temperature.
3.3.5. Cell metabolism
The concentrations of glucose, lactate, glutamine and ammonia
measured during run#1 and run#2 are shown in Fig. 4. These con-
centrations were comparable in the matrix, the harvest line and in
the bottom of the reservoir, illustrating that the ﬂuid composition
was homogeneous in the whole system. The lactate increased with
time in run#1 and ﬁnally reached 52 mM.  In run#2, it increased
to 86 mM on day 14 after which it decreased. The ammonia con-
centration became suddenly very high, 6.2 mM  on day 21 in run#1
Y. Zhang et al. / Journal of Biotechnology 213 (2015) 28–41 35
F iplied
2  the e
m
a
a
f
a
g
t
t
aig. 5. On-line biomass sensor monitoring. (A) Biomass, culture conductivity (mult
00  system from measured permittivity data, which subtracted the permittivity of
easured to calculate other parameters; (B) fc and alpha.
nd 8 mM on day 8 in run#2. In both cases, glutamine had been
lmost depleted and additional supplementations were performed
ollowed by sudden ammonia increase the next day. Likewise an
brupt ammonia increase was observed on day 5 in run#2 after
lutamine had been fed on day 4, although not depleted.
The high levels of lactate and ammonia were probably due to
he presence of glucose and glutamine at relatively high concentra-
ions, as showed by their residual concentrations of up to 20 mM
nd 3 mM,  respectively. by 100 to ﬁt the scale) and DeltaEsp. The biomass was calculated by the iBiomass
xperiment medium without any cells. The DeltaEsp was the permittivity variation
3.4. Production run at high density of growth-arrested cells
A production run, run#3, was conducted based on the learning’s
from run#1 and run#2.
From run#2, it was known that the CellTank supported high
cell density culture under cell growth arrest by temperature.
Run#1 showed that the CellTank supported densities up to
200 × 106 cells/mL hence selecting a density between 100 and
140 × 106 cells/mL allowed a large failure margin. It was  decided to
select a production process including cell growth arrest since this
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ype of process has the potential to generate a stable and long-term
gG production while a cell bleeding procedure from the matrix was
ot available.
It was observed in run#2 that the optimal temperature max-
mizing the cell speciﬁc productivity was 30 ◦C for this cell line.
owever, the results from this run showed some cell viability drop
t temperature ≤30 ◦C. Therefore the hypothermia temperature
nally selected for run#3 was 31 ◦C. Run#3 included a growth
hase, phase 1, followed by a two-weeks production phase at
1 ◦C hypothermia, phase 2, initiated when the cell density reached
00 pF/cm biomass reading. Towards the end of the run, the tem-
erature was restored to 37 ◦C to verify that the cells growth could
e re-initiated, phase 3. Finally, in run#3, the feed strategy of the
ubstrates was modiﬁed compared to the previous runs to reduce
he production of the by-products: the feeds of glucose and glu-
amine were minimized.
.4.1. Cell density
To reduce the time to achieve the target density of 100 pF/cm,
he culture was inoculated at 2 × 106 cells/mL. At day 13, the cell
ensity reached 97 pF/cm with a viability of 89% and the temper-
ture was decreased to 31 ◦C. At days 11 and 12, the cell growth
ecreased somewhat as well as the viability. After the tempera-
ure shift, the cell growth was signiﬁcantly reduced as can be seen
n Fig. 8 and stabilized around 100–120 pF/cm during 14 days. The
iability decreased with time down to 73.4% at day 27. The cell den-
ity in the reservoir slightly increased after the temperature shift
ntil a concentration of 0.55 × 106 cells/mL at day 27.
At day 28, the temperature was restored to 37 ◦C. After 3 days of
ag phase, the cell growth resumed however at a slower pace than
efore day 13.
After completion of the run, the CellTank was disassembled and
ll the disks of the matrix were individually removed. The cell dis-
ribution in the disks and the total number of cells in the matrix
ere analyzed as described in Section 2. A total number of about
30 × 106 cells/mL were counted in the matrix. This number was
imilar to the ﬁnal biomass reading from the on-line biomass probe,
52 × 106 cells/mL. It was not possible to completely dislodge allth matrix and harvest; (B) cell speciﬁc productivities qlgG in run#2 compared with
the cells from the matrix, however recovering 130 × 106 cells/mL
supported the ﬁnal reading from the biomass probe.
The cell distribution in the disk was  analyzed by observing slices
cut in the disk and by ﬁxing the cells in the matrix. It was observed
that the cells were loose inside the matrix, i.e., not adhering, and
were immediately released after the matrix had been cut. All the
disks exhibited a comparable and homogeneous distribution of the
cells through the disk and through the matrix although the bottom
disk exhibited somewhat more cell aggregates compared to the
other disks. This is illustrated in Fig. 9A–D showing four different
depths in the matrix: top (disk 1), median level (disks 5 and 6) and
bottom (disk 10). Fig. 9E illustrates how the cells were located in
the interstices of the matrix ﬁbers, showing DAPI staining of the cell
nuclei. Note that Fig. 9E picture was taken at a single plane so some
parts appear blurry. A stack of 56 pictures with 85.90 m depth
along the Z-axis helps to visualize the distribution of cells inside
the matrix in a deeper view (Zhang et al., 2015).
3.4.2. IgG production
At the end of the production phase 2 as shown in Fig. 10A, at day
27, 1.42 g IgG had been harvested in the 150 mL  CellTank prototype
with a total expense of 13 L medium. It was conﬁrmed that the
concentration in the harvest line was  similar to the one measured
in the matrix, leading to a 100% yield (data not showed).
3.4.3. Cell metabolism
Low glucose and glutamine feeds were adopted to minimize the
production of lactate and ammonia. The residual concentrations of
these substrates were 0 mM glucose from day 7 and between 0 and
0.6 mM glutamine most of the time as in Fig. 10B and C. Notice that
although their residual concentrations were very low, these sub-
strates were provided to the culture from the medium. The applied
perfusion rates obeyed consistently Eq (1). The residual lactate con-
centration was almost constant at a value lower than 40 mM during
the production phase at hypothermia, while the ammonia concen-
tration increased up to 5 mM.
It is probable that the metabolism shifted towards an increased
catabolism of the amino acids into the TCA cycle to compensate
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or the low glucose availability, generating a higher production of
mmonia.
. Discussion
The CellTank was a bioreactor easy to operate, with the
dvantages of integrating the cell separation device, reducing the
omplexity compared to systems with external cell separation
evice or external pumps for the recirculation. The centrifugal
ump offered an attractive alternative to the peristaltic pump for
he cells not entrapped in the matrix, avoiding the shear effect of
he pump head and the wall shear stress from recirculation in the
ube system. A drawback of the cell entrapment was  the absence
f cell sampling, requiring a supplementary method to measurenology 213 (2015) 28–41 37
the biomass. In this study, this was solved using a bioimpedance
measurement in the matrix.
4.1. Cell density
A cell density up to 200 × 106 cells/mL was obtained in run#1
and cell densities between 100 and 140 × 106 cells/mL were main-
tained during 11 and 14 days under cell growth arrest in runs #2
and #3. The cell growth was  slightly slower in run#3 compared
to run#2 at cell density above 75 × 106 cells/mL however in both
cases 100 × 106 cells/mL were successfully achieved. The cell via-
bility was  mostly higher than 90 % during runs #1 and #2. During
run#3, it decreased after day 12 and was 73.4 % at the end of
the two-weeks production phase under hypothermia. The cause
of the lower viability is not known. It can be speculated that the
shear stress is high in the system, in particular when the interstices
between the ﬁbers are reduced from the cell presence. The recir-
culation rate was set to 1.6 L/min however, at this stage, it has not
been optimized but could potentially be reduced in future work.
Most of the high cell densities above 100 × 106 cells/mL reported
in perfusion-integrated systems with immobilize or entrap cells,
have been achieved using hybridoma cells (Oh and Chang, 1992;
Wang et al., 1992; Zhu and Yang, 2004). The average cell diameter
for hybridoma cells is 15 m while the average live cell diameters
for the cell line used in the present study was 17 m,  as shown
in Table 2. In an earlier study we  have presented the theoretical
fraction of the volume occupied by the cells in a cell suspension
as a function of the cell diameter. From this study, with a cell
diameter of 15 m,  hybridoma cells at density of 187 × 106 and
101 × 106 cells/mL, occupy a fraction of 0.330 and 0.178, respec-
tively, while at 200 × 106, this fraction is 0.514 for CHO cells with
17 m diameter (Clincke et al., 2013b). The maximal biovolume
reported in the present study was thus much larger than previously
described. Additionally, the present results can also be bench-
marked against ﬁbrous-bed bioreactor where 101 × 106 hybridoma
cells/mL has been reached (Zhu and Yang, 2004). Although these
perfusion systems present the common feature of immobilizing
the cells in larger matrices like in the CellTank, the very efﬁcient
recirculation ﬂow of the CellTank enabled obtaining by far higher
cell densities and much more homogeneous environmental cul-
ture conditions as showed by similar proﬁles of the metabolites
measured at different locations of the CellTank.
Finally, the CellTank system can also be compared to stirred
tank bioreactor using other types of perfusion devices such as
ATF or TFF. We  have not performed a direct comparison of these
systems with this cell line. As a benchmarking, it can be men-
tioned that in all these systems, i.e., CellTank, ATF, TFF, we have
obtained cell densities by far above 100 × 106 cells/mL, i.e., up
to 180–214 × 106 cells/mL (Chotteau et al., 2013; Clincke et al.,
2013a,b). Although, the cell growth rate was somewhat slower
in run#3 above a density of 75 × 106 cells/mL, the CellTank could
support comparable cell growth as the ATF or TFF.
4.2. Perfusion rate, recirculation rate and feeding approach
The perfusion rate (calculated based on the matrix volume) was
tuned linearly with the cell density using a CSPR approach, except
when the by-product concentrations became too high in runs #1
and #2. In run#3, a CSPR around 0.05 nL/cell/day was consistently
applied. In this last run, a strategy of low substrate feeding was
also adopted: glucose and glutamine were scarcely added result-
ing in low residual concentrations of these substrates. This led to
moderate production of lactate and ammonia. CSPR strategy to tune
the perfusion rate has been successfully applied previously for very
high cell densities (Clincke et al., 2013b). Here it was shown that it
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AFig. 8. Cell growth proﬁles in run#3. Phase 1: cell growth phase; phase 2: prod
ould be applied for the CellTank as well, given that the substrate
eeds were limited.
The metabolite concentrations were similar in different loca-
ions of the CellTank, demonstrating that no gradient occurred in
he system. This presents a major advantage compared to other
ystems where the cells are entrapped or immobilized, since the
radients of substrates, gases and by-products can create local con-
ig. 9. Cells distribution inside the matrix visualized in slices cut in top disk (A); upper m
n  the cuts. (E) DAPI ﬂuorescence staining showing the distribution of the cells in the inte
able 2
verage live cell diameters measured by Bioproﬁle Flex with window 13 m-20 m for m
Run#1 Average Cell Diameter (m) 
Day 14 17.04 
Day  15 17.63 
Day  16 17.38 
Day  17 18.27 
Day  18 17.78 
Day  19 17.18 
Day  20 16.16 
Day  21 16.97 
Day  22 16.65 
Day  23 16.75 
Day  24 16.96 
Day  25 16.78 
Day  26 17.1 
Day  27 17.09  phase at temperature 31 ◦C; phase 3: new growth phase at temperature 37 ◦C.
ditions unfavorable for cells or the productivity, and can cause
non-homogeneous product quality.
A recirculation rate of 1.6 L/min was applied however this value
was not optimized in this ﬁrst proof-of-concept study. It is possible
that the shear stress associated to this recirculation rate was too
high and could possibly cause the lower viability observed in run#3.
It will be interesting in future work to decrease this rate.
iddle disk (B); lower middle disk (C); bottom disk (D). Only ﬁber pieces are visible
rstices between the ﬁbers.
in.-max. cell size based on off-line image analysis for matrix samples.
Run#2 Average Cell Diameter (m)
Day 7 16.60
Day 8 17.06
Day 9 16.26
Day 10 16.84
Day 11 16.95
Day 12 16.67
Day 13 16.75
Day 14 17.00
Day 15 16.71
Day 16 16.17
Day 17 16.82
Day 18 17.26
Day 19 17.44
Day 20 17.48
Day 21 17.48
Day 22 17.31
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hase;  (B) glucose and lactate concentrations; (C) glutamine and ammonia concent
.3. IgG production
An IgG production of 1.42 g was achieved during a production
un in a matrix bioreactor of 150 mL  volume using the low producer
HO cell line DP12. Using the same cell line, we measured in a pro-
uctivity test that a batch process would have generated 54 mg/L
fter a 6-days batch production run reaching 6.15 × 106 cells/mL in
hake ﬂask. In other words, for a production campaign of 30 days,
0.5 mg  IgG could be produced in a volume of 150 mL,  compared
o a production of 1.42 g achieved using the CellTank, i.e., 35 fold
ore product during the same time period.
No IgG retention was observed in the system. Retention of the
roduct of interest is an important issue for ﬁlter-based cell reten-
ion devices where it is often observed and aggravated at higher
ell densities (Clincke et al., 2013a; de la Broise et al., 1992). The
bsence of retention in the CellTank system is a favorable feature,
hich could be due to the fast recirculation ﬂow or to the matrix
aterial, i.e., polyester, or to a combination of these factors.
A hypothermia strategy was applied to arrest the cell growth and
nhance the production. The CellTank, in its present version, does
ot allow easy detaching and harvesting the cells during the opera-
ion. To decrease the temperature is thus an efﬁcient way to control
he cell density as has been showed by others (Ducommun et al.,
002b). The effect of temperature shift depends on the cell line. Inpling locations during run#3. (A) Accumulated IgG until the end of the production
s.
the present study, we successfully showed that it was  possible to
lower the temperature to arrest the cell growth at cell densities
≥100 × 106 cells/mL and to increase the cell speciﬁc productivity.
Reducing progressively the temperature was  a simple method to
identify the optimal production temperature.
We observed that no fragment variant occurred in the culture at
37 ◦C up to the very high density of 200 × 106 cells/mL. Hypother-
mia  was associated with the occurrence of a variant of the light
chain with an intensity increasing with decreasing temperature.
Variations in the IgG light chain glycosylation have been reported
(Holland et al., 2006; Jefferis, 2005, 2009; Mimura et al., 2007;
Rustandi et al., 2008; Tachibana et al., 1993) and hypothermia is
known to be a potential cause of these variations (Ahn et al., 2008;
Bollati-Fogolin et al., 2005; Tharmalingam et al., 2008; Trummer
et al., 2006; Yoon et al., 2003). It is highly probable that the light
chain variations observed here were due to a different glycosyla-
tion.
5. Conclusions and perspectiveA new disposable perfusion bioreactor, CellTank, integrating
the cell separation device was  investigated. In this system, the
cells were entrapped in a non-woven polyester matrix, perfused
by the culture medium. In this current study, three runs were
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erformed at cell densities above 100 pF/cm, where 1 pF/cm was
quivalent to 1 × 106 viable cells/mL up to a cell density of
60 × 106 cells/mL. In the ﬁrst run aimed at studying the cell den-
ity capacity of the bioreactor, a maximal cell density of 200 pF/cm
as reached. In the second run, hypothermia at temperature
32 ◦C was applied to the culture to arrest the cell growth and to
ncrease cell productivity. The density stabilized between 100 × 106
nd 130 × 106 cells/mL during 13 days. Hypothermia at 31 ◦C was
elected for a production run, run#3, applied after the cell density
eached 100 × 106 cells/mL. Despite the use of a cell line adapted
o cell suspension and a very fast recirculation ﬂow of 1.6 L/min
etween the matrix and the reservoir, i.e., 10.7 VVM (volume per
olume per minute), the cells mostly remained entrapped inside
he matrix. It was observed that when the cell growth was  par-
ially arrested by hypothermia, a higher proportion of the cells were
islodged from the matrix. The bioreactor had been designed to
chieve a homogeneous distribution of the medium component in
he whole system and it was indeed demonstrated that no gradi-
nts occurred in this system even at very high cell densities. No
gG retention in the bioreactor was observed up to a cell density of
00 pF/cm.
Inherently to the concept of the CellTank, based on cell entrap-
ent, there was no way to operate cell bleeding to maintain the cell
ensity at a stable level. During the operation, it was  observed that
ncreasing the recirculation rate could provoke the cell detachment
rom the matrix, in particular when abrupt variations of this rate
ere applied (data showed). This feature could be systematically
xploited in future work to enable the cell detachment to harvest
r bleed the cells.
The scale-up of the system was not studied in the present proof-
f-concept study but theoretical considerations can be made here.
he system can be enlarged in height and in diameter. The 150 mL
ellTank contains two envelopes including ﬁve disks each and ori-
nted with angles optimized to obtain a homogeneous and efﬁcient
ow distribution. The system can be enlarged by adding supple-
entary double envelops (each containing two times ﬁve disks) in
eight, i.e., increasing the height of the cassette to include a larger
umber of disks, while enlarging the centrifugal pump capacity and
ower input. This scale-up is only an extension of the actual design
nd can generate a matrix volume of 15 × 150 mL,  i.e., 2250 mL.  The
nlargement of the system in diameter will require a new optimiza-
ion of the envelope design.
The CellTank is a compact system for the production of biologics,
upporting very high cell densities, with the capacity to be enlarged
o several liters. The bioreactor settings do not require a cell spe-
iﬁc optimization. In a one-month campaign, the 150 mL  CellTank
as the capacity to generate several grams of product of interest,
epending on the cell speciﬁc productivity. Hence this system can
e used to produce material for diagnostics, as research tool or for
arly stage manufacturing. The ﬁeld of application of the up-scaled
ellTank will be the production of several tens to hundreds of grams
f product of interest.
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